Position in NVS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$125,376
+$3,176 QoQ
Shares Held
800
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,352
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EDMOND DE ROTHSCHILD HOLDING S.A. holds $290,206,318 across 12 Drug Manufacturers - General names. NVS ranks #11 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
411,773 | $78,080,395 | |
| 2 | LLY |
ELI LILLY & Co
|
52,884 | $63,430,658 | |
| 3 | MRK |
Merck & Co., Inc.
|
399,582 | $51,346,286 | |
| 4 | PFE |
Pfizer Inc
|
1,455,651 | $35,052,075 | |
| 5 | JNJ |
Johnson & Johnson
|
78,892 | $20,036,200 | |
| 6 | ABBV |
AbbVie Inc.
|
49,869 | $12,549,032 | |
| 7 | BIIB |
Biogen Inc.
|
56,064 | $12,113,187 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
83,510 | $10,550,651 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $125,376 | 800 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $122,200 | 800 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $110,296 | 800 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $102,592 | 800 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $96,808 | 800 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $89,184 | 800 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $77,848 | 800 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $92,016 | 800 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $85,168 | 800 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $77,384 | 800 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $80,776 | 800 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $81,488 | 800 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $80,728 | 800 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $73,600 | 800 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $158,034 | 1,742 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $176,951 | 2,328 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $204,985 | 2,425 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $273,165 | 3,113 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $246,402 | 2,817 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $162,415 | 1,986 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $72,992 | 800 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $68,384 | 800 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $75,544 | 800 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $69,568 | 800 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $100,441 | 1,150 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $94,817 | 1,150 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||